Display options
Cite
Bozkurt E, Keleş T, Durmaz T, et al. Early outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: single center experience. Postepy Kardiol Interwencyjnej. 2014;10(2):84-90doi: 10.5114/pwki.2014.43511.
Bozkurt, E., Keleş, T., Durmaz, T., Akçay, M., Sari, C., Ayhan, H., Bayram, N. A., Aslan, A. N., Baştuğ, S., & Bilen, E. (2014). Early outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: single center experience. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 10(2), 84-90. https://doi.org/10.5114/pwki.2014.43511
Bozkurt, Engin, et al. "Early outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: single center experience." Postepy w kardiologii interwencyjnej = Advances in interventional cardiology vol. 10,2 (2014): 84-90. doi: https://doi.org/10.5114/pwki.2014.43511
Bozkurt E, Keleş T, Durmaz T, Akçay M, Sari C, Ayhan H, Bayram NA, Aslan AN, Baştuğ S, Bilen E. Early outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: single center experience. Postepy Kardiol Interwencyjnej. 2014;10(2):84-90. doi: 10.5114/pwki.2014.43511. Epub 2014 Jun 26. PMID: 25061453; PMCID: PMC4108731.
Copy Download .nbib Format: NLM
Share it on

Postepy Kardiol Interwencyjnej. 2014;10(2):84-90. doi: 10.5114/pwki.2014.43511. Epub 2014 Jun 26.

Early outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: single center experience.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

Engin Bozkurt, Telat Keleş, Tahir Durmaz, Murat Akçay, Cenk Sari, Hüseyin Ayhan, Nihal Akar Bayram, Abdullah Nabi Aslan, Serdal Baştuğ, Emine Bilen

Affiliations

  1. Cardiology Department, Y?ld?r?m Beyaz?t University, Ankara, Turkey.
  2. Cardiology Department, Ataturk Training and Research Hospital, Ankara, Turkey.

PMID: 25061453 PMCID: PMC4108731 DOI: 10.5114/pwki.2014.43511

Abstract

INTRODUCTION: Transcatheter aortic valve implantation is a promising alternative to high risk surgical aortic valve replacement. The procedure is mainly indicated in patients with severe symptomatic aortic stenosis who cannot undergo surgery or who are at very high surgical risk.

AIM: Description early results of our single-center experience with balloon expandable aortic valve implantation.

MATERIAL AND METHODS: Between July 2011 and August 2012, we screened in total 75 consecutive patients with severe aortic stenosis and high risk for surgery. Twenty-one of them were found ineligible for transcatheter aortic valve implantation (TAVI) because of various reasons, and finally we treated a total of 54 patients with symptomatic severe aortic stenosis (AS) who could not be treated by open heart surgery (inoperable) because of high-risk criteria. The average age of the patients was 77.4 ±7.1; 27.8% were male and 72.2% were female. The number of patients in NYHA class II was 7 while the number of patients in class III and class IV was 47.

RESULTS: The average mortality score of patients according to the STS scoring system was 8.5%. Pre-implantation mean and maximal aortic valve gradients were measured as 53.2 ±14.1 mm Hg and 85.5 ±18.9 mm Hg, respectively. Post-implantation mean and maximal aortic valve gradients were 9.0 ±3.0 and 18.2 ±5.6, respectively (p < 0.0001). The left ventricular ejection fraction was calculated as 54.7 ±14.4% before the operation and 58.0 ±11.1% after the operation (p < 0.0001). The duration of discharge after the operation was 5.29 days, and a statistically significant correlation between the duration of discharge after the operation and STS was found (r = 0385, p = 0.004).

CONCLUSIONS: We consider that with decreasing cost and increasing treatment experience, TAVI will be used more frequently in broader indications. Our experience with TAVI using the Edwards-Sapien XT (Edwards Lifesciences, Irvine, CA) devices suggests that this is an effective and relatively safe procedure for the treatment of severe aortic stenosis in suitable patients.

Keywords: transcatheter aortic valve replacement

References

  1. N Engl J Med. 2010 Oct 21;363(17):1597-607 - PubMed
  2. Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):533-9 - PubMed
  3. Ann Thorac Surg. 2006 Dec;82(6):2111-5 - PubMed
  4. JACC Cardiovasc Interv. 2008 Jun;1(3):305-9 - PubMed
  5. EuroIntervention. 2010 Jan;5(6):673-9 - PubMed
  6. Circulation. 2008 Oct 7;118(15):e523-661 - PubMed
  7. Catheter Cardiovasc Interv. 2012 Nov 15;80(6):956-63 - PubMed
  8. Herz. 2009 Aug;34(5):398-408 - PubMed
  9. J Thorac Cardiovasc Surg. 2008 Oct;136(4):948-53 - PubMed
  10. Circulation. 2002 Dec 10;106(24):3006-8 - PubMed
  11. Am J Cardiol. 1988 Jan 1;61(1):123-30 - PubMed
  12. Turk Kardiyol Dern Ars. 2010 Jun;38(4):258-63 - PubMed
  13. J Am Coll Cardiol. 2010 Jan 19;55(3):186-94 - PubMed
  14. Eur Heart J. 2011 Jan;32(2):191-7 - PubMed
  15. Eur Heart J. 2005 Dec;26(24):2714-20 - PubMed
  16. Heart. 1999 Aug;82(2):143-8 - PubMed
  17. Eur Heart J. 2011 Jan;32(2):198-204 - PubMed
  18. Circulation. 2007 Aug 14;116(7):755-63 - PubMed
  19. Tex Heart Inst J. 2012;39(3):351-8 - PubMed
  20. N Engl J Med. 2012 May 3;366(18):1705-15 - PubMed
  21. Circ Cardiovasc Interv. 2008 Dec;1(3):167-75 - PubMed
  22. J Am Coll Cardiol. 2006 Mar 21;47(6):1214-23 - PubMed
  23. Turk Kardiyol Dern Ars. 2012 Sep;40(6):527-31 - PubMed
  24. Eur Heart J. 1987 May;8(5):471-83 - PubMed
  25. J Am Coll Cardiol. 2011 Jan 18;57(3):253-69 - PubMed
  26. EuroIntervention. 2010 Jan;5(6):659-65 - PubMed
  27. Am J Cardiol. 1993 Oct 1;72(11):846-8 - PubMed
  28. Ann Thorac Surg. 2003 Jun;75(6):1856-64; discussion 1864-5 - PubMed
  29. Circulation. 2011 Jul 26;124(4):425-33 - PubMed
  30. Eur Heart J. 2008 Jun;29(11):1410-7 - PubMed

Publication Types